Related Experiment Videos

Intraluminal recanalization of long infrainguinal chronic total occlusions using the Crosser system

Roberto Gandini1, Tommaso Volpi, Vincenzo Pipitone

  • 1Department of Diagnostic and Molecular Imaging, University of Rome Tor Vergata, Rome, Italy.

Insights

The Crosser CTO Recanalization System safely and effectively opened long blocked leg arteries in 75% of patients, reducing procedure time for chronic total occlusions (CTO). This vibrational angioplasty device shows promise for critical limb ischemia treatment.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Chronic total occlusions (CTO) in the infrainguinal arteries often lead to critical limb ischemia.
  • Conventional guidewire techniques have limited success in recanalizing long CTOs.
  • Novel devices are needed to improve recanalization rates and reduce procedural times.

Purpose of the Study:

  • To evaluate the safety and efficacy of the Crosser CTO Recanalization System.
  • To assess its performance in percutaneous intraluminal recanalization of long infrainguinal CTOs.
  • To determine its utility in patients with critical limb ischemia resistant to conventional methods.

Main Methods:

  • The Crosser CTO Recanalization System utilizes high-frequency vibrational energy to navigate fibrocalcific plaque.
  • A prospective study was conducted on 12 diabetic patients with long infrainguinal CTOs.
  • The device was used in cases resistant to standard guidewire techniques.

Main Results:

  • The Crosser system successfully crossed the CTO in 9 out of 12 patients (75%) within 5 minutes.
  • The mean crossing time was 4 minutes and 3 seconds.
  • The safety endpoint, defined as no vessel perforation or dissection, was achieved in all successful recanalizations.

Conclusions:

  • The Crosser CTO Recanalization Catheter demonstrated a high rate of successful intraluminal recanalization for long infrainguinal CTOs.
  • The device proved to be safe in this preliminary patient cohort.
  • It significantly decreased procedural crossing time, offering a potential advancement in treating complex arterial occlusions.
Abstract

Related Concept Videos